4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001213900-26-106400
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Smith Nancy Freda Director | 2026-09-22 | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | D | ||
Loading xslF345X06/ownership.xml…